Reflex vascular responses to vasoactive substances.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001808:Blood Vessels / Q000187:drug effects*; D002346:Carotid Sinus / Q000502:physiology; D002415:Cats; D002628:Chemoreceptor Cells; D003250:Constriction; D003714:Denervation; D003891:Desipramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004106:Dilatation; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D006614:Hindlimb; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D008297:Male; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011311:Pressoreceptors / Q000187:drug effects; D011758:Pyrroles / Q000494:pharmacology; D012018:Reflex / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013618:Tachyphylaxis / Q000187:drug effects; D014309:Tripelennamine / Q000494:pharmacology; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology; D014702:Veratrine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D005730:Ganglionic Blockers; D006634:Histamine H1 Antagonists; D011758:Pyrroles; D000804:Angiotensin II; D014309:Tripelennamine; D001285:Atropine; D006632:Histamine; D014702:Veratrine; D003891:Desipramine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine